Cargando…
Salinomycin: Anti-tumor activity in a pre-clinical colorectal cancer model
OBJECTIVES: Salinomycin is a polyether antibiotic with selective activity against human cancer stem cells. The impact of salinomycin on patient-derived primary human colorectal cancer cells has not been investigated so far. Thus, here we aimed to investigate the activity of salinomycin against tumor...
Autores principales: | Klose, Johannes, Trefz, Stefan, Wagner, Tobias, Steffen, Luca, Preißendörfer Charrier, Arsalie, Radhakrishnan, Praveen, Volz, Claudia, Schmidt, Thomas, Ulrich, Alexis, Dieter, Sebastian M., Ball, Claudia, Glimm, Hanno, Schneider, Martin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6375586/ https://www.ncbi.nlm.nih.gov/pubmed/30763370 http://dx.doi.org/10.1371/journal.pone.0211916 |
Ejemplares similares
-
Salinomycin inhibits metastatic colorectal cancer growth and interferes with Wnt/β-catenin signaling in CD133(+) human colorectal cancer cells
por: Klose, Johannes, et al.
Publicado: (2016) -
Salinomycin inhibits cholangiocarcinoma growth by inhibition of autophagic flux
por: Klose, Johannes, et al.
Publicado: (2017) -
Colorectal cancer‐initiating cells caught in the act
por: Dieter, Sebastian M, et al.
Publicado: (2017) -
Impact of Salinomycin on human cholangiocarcinoma: induction of apoptosis and impairment of tumor cell proliferation in vitro
por: Lieke, Thorsten, et al.
Publicado: (2012) -
High hepatic expression of PDK4 improves survival upon multimodal treatment of colorectal liver metastases
por: Strowitzki, Moritz J., et al.
Publicado: (2019)